Attitudes of Canadian Radiation Oncologists towards Post-lumpectomy Radiotherapy for Elderly Women with Stage I Hormone-responsive Breast Cancer
Conclusions: Although there is significant variation in practice patterns and attitudes among radiation oncologists regarding post-lumpectomy radiotherapy for elderly, low-risk breast cancer patients, the vast majority value patient choice and would be willing to use a decision aid designed for this population in their practice. (Source: Clinical Oncology)...
POSTED 02/03/2010 at 09:36 AM --
|
Routine Preoperative MRI for Breast Carcinoma
The article published by Bleicher and colleagues regarding the role of routine MRI on newly diagnosed breast carcinoma and its impact on time of operation, mastectomy rate, and margin of lumpectomy status is highly commendable. (Source: Journal of the American College of Surgeons)...
POSTED 01/27/2010 at 09:29 AM --
|
[Lobular intra-epithelial neoplasia: Atypical lobular hyperplasia and lobular carcinoma in situ.]
Authors: Ansquer Y, Santulli P, Colas C, Jamali M, Tournigand C, Duperray L, Duperray B, Jannet D, Carbonne B
OBJECTIVE: To review main knowledge about lobular intra-epithelial neoplasia with special interest for daily practice management. MAIN RESULTS: Intra-epithelial lobular neoplasias (ILN) are non invasive proliferations within the terminal ducto-lobular unit of monomorphic loosely cohesive small cells. A lack of expression of the E-cadherin adhesion molecule is often observed as in invasive lobular breast cancer. ILN are infrequent, however, a rise in incidence partly, due to the generalization of mammographic screening, is observed. Actually ILN are usually asymptomatic and diagnosed after breast biopsy for unspecified microcalcifications. ILN are associated with an increased ri......
POSTED 01/26/2010 at 06:00 PM --
|
Cryoablation FA Visica
Cryoablation is an alternative way to remove breast fibroadenomas. Instead of having a lumpectomy to remove a fibroadenoma, cryoablation uses intense cold to freeze the unwanted tissue to death. Learn more about cryoablation of breast fibroadenomas here. (Source: About.com Breast Cancer)...
POSTED 01/25/2010 at 06:00 PM --
|
Identification of residual breast tumour localization after neo-adjuvant chemotherapy using a radioactive 125 Iodine seed
Conclusion: This study has shown that 125I seed localization is a novel and highly successful technique in localizing the tumour bed in patients who receive neo-adjuvant chemotherapy for breast cancer leading to a high percentage of radical margins in case of breast-conserving surgery. (Source: European Journal of Surgical Oncology)...
POSTED 01/22/2010 at 07:47 AM --
|
Histology after lumpectomy in women with epithelial atypia on stereotactic vacuum-assisted breast biopsy
Conclusion: ADH diagnosed by vacuum-assisted breast biopsy frequently corresponds to cancer on open surgical biopsy. Surgical excision of all breast lesions containing atypical hyperplasia on percutaneous biopsy can be recommended. (Source: European Journal of Surgical Oncology)...
POSTED 01/22/2010 at 07:47 AM --
|
The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ
This study suggests that although oncoplastic reduction techniques are a reasonable approach for women with DCIS, stricter patient selection and improved confirmation of negative margins will minimize the need for either re-excisions or completion mastectomy and reconstruction. (Source: The Breast Journal)...
POSTED 01/18/2010 at 06:00 PM --
|
The effect of intraoperative specimen inking on lumpectomy
re-excision rates
Conclusions:
Intraoperative inking in this practice offered a simple way to reduce re-excision rates after lumpectomy and affect an improvement in quality of patient care (Source: World Journal of Surgical Oncology)...
POSTED 01/17/2010 at 06:00 PM --
|
Novilase
In a clinical trial of Novilase Laser Ablation techonology, breast fibroadenomas can be effectively treated without a lumpectomy. Breast fibroadenomas can be bothersome if they are large or swell, but laser ablation destroys this benign breast tumor. Learn more about laser ablation of breast fibroadenomas here. (Source: About.com Breast Cancer)...
POSTED 01/06/2010 at 06:00 PM --
|
Smile! You've got cancer | Barbara Ehrenreich
Cancer is not a problem or an illness – it's a gift. Or so Barbara Ehrenreich was told repeatedly after her diagnosis. But the positive thinkers are wrong, she says: sugar-coating illnesses can exact a dreadful costIf you had asked me, just before the diagnosis of cancer, whether I was an optimist or a pessimist, I would have been hard-pressed to answer. But on health-related matters, as it turned out, I was optimistic to the point of delusion. Nothing had so far come along that could not be controlled by diet, stretching, painkillers or, at worst, a prescription. So I was not at all alarmed when a routine mammogram aroused some "concern" on the part of my gynaecologist.How could I have breast cancer? I had no known risk factors, there was no breast cancer in the fami......
POSTED 01/01/2010 at 06:18 PM --
|
Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens.
CONCLUSIONS: Frequency of residual invasive carcinoma was related to margin status of the original lumpectomy/biopsy. Even when margins were positive, most reexcisions were free of carcinoma. Residual invasive carcinoma was found in greater than 25% of patients with margins less than 2 mm, supporting reexcision for patients with margins of less than 2 mm. Sixteen percent of cases with margins greater than 2 mm harbored residual invasive carcinoma. Evaluation of margin status was complicated by tissue distortion and fragmentation.
PMID: 20073613 [PubMed - in process] (Source: Archives of Pathology and Laboratory Medicine)...
POSTED 12/31/2009 at 06:00 PM --
|
3D-conformal Accelerated Partial Breast Irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity
Conclusions:
The placement of surgical clips improved the accuracy of lumpectomy cavity delineation in 3D-APBI. However, a learning curve is needed to improve the conformity index of the lumpectomy cavity. (Source: Radiation Oncology)...
POSTED 12/30/2009 at 06:00 PM --
|
Teresa Heinz Kerry Treated For Breast Cancer
Teresa Heinz KerryPhoto ©Getty Images/Jeff Swensen
Teresa Heinz Kerry and Elizabeth Edwards now have more in common than being part of the 2004 presidential campaign. While John Kerry and John Edwards ran for office, Elizabeth discovered a lump in her breast and was eventually treated for metastatic breast cancer. Nine years later, Teresa Heinz Kerry, heiress to the Heinz ketchup fortune, has announced that she has breast cancer.
Kerry, 71, said that her lump was detected during a routine screening mammogram. "The cancer was detected at an early stage thanks to a mammogram and the work of a remarkable physician who insisted on investigating beyond what the mammogram could show," said Kerry. Stage one breast cancer was found in both breasts, for which Kerry had lumpectomies. After surger......
POSTED 12/25/2009 at 06:00 PM --
|
Study Finds Racial Disparities Exist In Radiation Therapy Rates For Early Stage Breast Cancer
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. (Source: Cancercompass News: Breast Cancer)...
POSTED 12/22/2009 at 06:00 PM --
|
True Recurrences and New Primary Tumors Have Different Clinical Features in Invasive Breast Cancer Patients with Ipsilateral Breast Tumor Relapse After Breast-Conserving Treatment
Abstract: Ipsilateral breast tumor relapse (IBTR) after breast-conserving treatment (BCT) may represent two distinct types of lesion, including a true recurrence (TR) or a new primary tumor (NPT). The aim of this study was to ascertain the difference between TRs and NPTs and to show the clinical significance of classifying IBTR into these two types of recurrence. Patients (n = 2,075) with unilateral invasive breast cancer who underwent BCT between 1987 and 2005 at Saitama Cancer Center were analyzed. IBTR was classified into TR and NPT, which was based on all clinical and pathological features of both a primary tumor and IBTR that can be evaluated. IBTR-free survival and the risk factors were analyzed in order to compare the findings for TR and NPT. In addition, the salvage surgical method......
POSTED 12/20/2009 at 06:00 PM --
|
Racial Disparities in Radiation Therapy
After a lumpectomy, black women are far less likely than white women to receive radiation therapy, the standard of care for early stage breast cancer. (Source: Medical Headlines From Ivanhoe.com)...
POSTED 12/15/2009 at 11:00 PM --
|
After Lumpectomy, Radiation Rates Lower for Black Women
Racial disparities seen for 'standard-of-care' breast cancer treatment, study finds (Source: Forbes.com Health News)...
POSTED 12/14/2009 at 08:00 AM --
|
After Lumpectomy, Radiation Rates Lower for Black Women
Racial disparities seen for 'standard-of-care' breast cancer treatment, study finds Source: HealthDay
Related MedlinePlus Topics: Health Disparities, Mastectomy, Radiation Therapy (Source: MedlinePlus Health News)...
POSTED 12/14/2009 at 08:00 AM --
|
Racial Disparities Exist In Radiation Therapy Rates For Early Stage Breast Cancer
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. The largest of its kind and the first to examine such racial disparities in radiation therapy, the study was published today in Cancer... (Source: Radiology / Nuclear Medicine News From Medical News Today)...
POSTED 12/14/2009 at 06:00 AM --
|
Promising Results Reported In Cell-Enriched Breast Reconstruction Trial
Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched breast reconstruction achieved a high rate of patient and physician satisfaction and improvements in overall breast deformity in lumpectomy patients. These results are based on six-month follow up from the first 32 women enrolled and treated. The results were presented at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (Poster #4123) by Dr. Eva Weiler-Mithoff, M.D., co-principal investigator for the Restore 2 Trial at the Glasgow Royal Infirmary... (Source: Health News from Medical News Today)...
POSTED 12/14/2009 at 06:00 AM --
|
